Rheumatology Flashcards
What are the key presenting features in RA (new diagnosis)?
bilateral swollen, painful joints in hands and feet (PIP and MCP)
stiffness worse in the morning, improves with use
gradually gets worse with larger joints becoming involved
presentation usually develops over a few months
positive ‘squeeze test’ - discomfort on squeezing across the metacarpal or metatarsal joints
OR less common presentations:
acute onset with marked systemic disturbance
relapsing/remitting monoarthritis of different large joints (palindromic rheumatism)
What are late features of RA?
Swan neck and boutonnière deformities
How is RA diagnosed?
Clinical diagnosis is the most important thing
2010 American College of Rheumatology criteria
- used for patients with at least 1 joint with definite clinical synovitis that is not better explained by another disease
- need a score of 6/10 for diagnosis
Categories:
joint involvement, serology, acute phase reactants, duration of symptoms
How is RA investigated?
Antibodies:
Rheumatoid Factor: RF is a circulating antibody (usually IgM) that reacts with the Fc portion of the patients IgG. It is the first-line antibody test for patients with suspected RA.
Rose-Waaler test for RF: sheep red cell agglutination
Latex agglutination test for RF(less specific)
Anti-CCP Antibodies : allows early detection of patients suitable for aggressive anti-TNF therapy (present before symptoms)
X-Rays of hands and feet
What are the X-ray findings in RA?
Early x-ray findings:
loss of joint space
juxta-articular osteoporosis
soft-tissue swelling
Late x-ray findings:
periarticular erosions
subluxation
What is the first line tx for RA?
DMARD monotherapy +/- a short-course of bridging prednisolone
Example DMARDs:
methotrexate is the most widely used DMARD. Monitoring of FBC & LFTs is essential due to the risk of myelosuppression and liver cirrhosis. Other important side-effects include pneumonitis
sulfasalazine
leflunomide
hydroxychloroquine
How is response to tx monitored in RA? When flares are picked up how are they managed?
using a combination of CRP and disease activity (using a composite score such as DAS28)
flares of RA are often managed with corticosteroids - oral or intramuscular
Give some extra-articular complications of RA (think in a head to toe manner to remember)
neuro: depression
ocular: keratoconjunctivitis sicca (most common), scleritis, corneal ulceration, keratitis, steroid-induced cataracts, chloroquine retinopathy
cardio: ischaemic heart disease (RA carries a similar risk to type 2 diabetes mellitus)
respiratory: pulmonary fibrosis, pleural effusion, pulmonary nodules, bronchiolitis obliterans, methotrexate pneumonitis, pleurisy
MSK: osteoporosis
Also increased risk of infections
What is Felty’s syndrome?
RA + splenomegaly + low white cell count
Give some poor prognostic features in RA
rheumatoid factor positive
anti-CCP antibodies
poor functional status at presentation
X-ray: early erosions (e.g. after < 2 years)
extra articular features e.g. nodules
HLA DR4
insidious onset
What is SLE?
a multisystem, autoimmune disorder
type 3 hypersensitivity reaction - caused by immune complex deposition
It typically presents in early adulthood and is more common in women and people of Afro-Caribbean origin.
Give some general presenting features of SLE
fatigue
fever
mouth ulcers
lymphadenopathy
Presentation of SLE in the skin?
malar (butterfly) rash: spares nasolabial folds
discoid rash: scaly, erythematous, well demarcated rash in sun-exposed areas. Lesions may progress to become pigmented and hyperkeratotic before becoming atrophic
photosensitivity
Raynaud’s phenomenon
livedo reticularis
non-scarring alopecia
MSK manifestations of SLE?
arthralgia
non-erosive arthritis
Cardiac manifestations of SLE?
pericarditis: the most common cardiac manifestation
myocarditis
Respiratory manifestations of SLE?
pleurisy
fibrosing alveolitis
Renal manifestations of SLE?
proteinuria
glomerulonephritis (diffuse proliferative glomerulonephritis is the most common type)
How is SLE investigated?
Antibodies:
99% are ANA positive
(this high sensitivity makes it a useful rule out test, but it has low specificity)
20% are rheumatoid factor positive
anti-dsDNA: highly specific (> 99%), but less sensitive
anti-Smith
also: anti-U1 RNP, SS-A (anti-Ro) and SS-B (anti-La)
How is SLE disease progression monitored?
Inflammatory markers:
ESR is generally used
during active disease the CRP may be normal - a raised CRP may indicate underlying infection
complement levels (C3, C4) are low during active disease (formation of complexes leads to consumption of complement)
How is SLE managed?
Hydroxychloroquine first line
NSAIDs and suncream important
If internal organ involvement e.g. renal, neuro, eye then consider prednisolone, cyclophosphamide
Lupus nephritis is a severe manifestation of SLE that can result in end-stage renal disease. Patients should be monitored by performing urinalysis at regular check-up appointments to rule out proteinuria.
How is lupus nephritis managed?
treat hypertension
initial therapy for focal (class III) or diffuse (class IV) lupus nephritis: glucocorticoids with either mycophenolate or cyclophosphamide
subsequent therapy : mycophenolate is generally preferred to azathioprine to decrease the risk of developing end-stage renal disease
Ankylosing spondylitis is a HLA-B27 associated spondyloarthropathy. It typically presents in males (sex ratio 3:1) aged 20-30 years old.
What are its key presenting features?
typically a young man who presents with lower back pain and stiffness of insidious onset
stiffness is usually worse in the morning and improves with exercise
the patient may experience pain at night which improves on getting up
What are the As of ankylosing spondylitis?
Anterior uveitis
Apical fibrosis
Aortic regurgitation
AV node block
Achilles tendonitis
Amyloidosis
and cauda equina syndrome
peripheral arthritis
What will be seen on examination in ankylosing spondylitis?
reduced lateral flexion
reduced forward flexion - Schober’s test - a line is drawn 10 cm above and 5 cm below the back dimples (dimples of Venus). The distance between the two lines should increase by more than 5 cm when the patient bends as far forward as possible
reduced chest expansion